References
- Bilani N, Elson L, Liang H, Elimimian EB, Arteta-Bulos R, Nahleh Z. Prognostic and predictive value of circulating and disseminated tumor cells in breast cancer: A National Cancer Database (NCDB) analysis. Technol Cancer Res Treat 2020; 19: 1533033820980107. doi: 10.1177/1533033820980107
- Theil G, Fornara P, Bialek J. Position of circulating tumor cells in the clinical routine in prostate cancer and breast cancer patients. Cancers 2020; 12: 3782. doi: 10.3390/cancers12123782
- Lozar T, Gersak K, Cemazar M, Grasic Kuhar C, Jesenko T. The biology and clinical potential of circulating tumor cells. Radiol Oncol 2019; 53: 131–47. doi: 10.2478/raon-2019-0024
- Grosse-Wilde A, Fouquier d’Hérouël A, McIntosh E, Ertaylan G, Skupin A, Kuestner RE, et al. Stemness of the hybrid epithelial/mesenchymal state in breast cancer and its association with poor survival. PLoS One 2015; 10: e0126522. doi: 10.1371/journal.pone.0126522
- Jolly MK, Boareto M, Huang B, Jia D, Lu M, Ben-Jacob E, et al. Implications of the hybrid epithelial/mesenchymal phenotype in metastasis. Front Oncol 2015; 5:155. doi: 10.3389/fonc.2015.00155
- Riethdorf S, Fritsche H, Muller V, Rau T, Schindlbeck C, Rack B, et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch System. Clin Cancer Res 2007; 13: 920–8. doi: 10.1158/1078-0432.CCR-06-1695
- Hu XC, Wang Y, Shi DR, Loo TY, Chow LWC. Immunomagnetic tumor cell enrichment is promising in detecting circulating breast cancer cells. Oncology 2003; 64: 160–5. doi: 10.1159/000067776
- Lozar T, Jesenko T, Kloboves Prevodnik V, Cemazar M, Hosta V, Jericevic A, et al. Preclinical and clinical evaluation of magnetic-activated cell separation technology for CTC isolation in breast cancer. Front Oncol 2020; 10: 554554. doi: 10.3389/fonc.2020.554554.
- Miller MC, Robinson PS, Wagner C, O’Shannessy DJ. The ParsortixTM cell separation system — a versatile liquid biopsy platform. Cytometry A 2018; 93: 1234–9. doi: 10.1002/cyto.a.23571
- Huang Q, Hu X, He W, Zhao Y, Hao S, Wu Q, et al. Fluid shear stress and tumor metastasis. Am J Cancer Res 2018; 8: 763–777. PMID: 29888101
- Lowe AC, Pignon JC, Carvo I, Drage MG, Constantine NM, Jones N, et al. Young investigator challenge: application of cytologic techniques to circulating tumor cell specimens: detecting activation of the oncogenic transcription factor STAT3. Cancer Cytopathol 2015; 123: 696–705. doi: 10.1002/ cncy.21640
- Kamal M, Macall L, Horton C, Hills N, Davis R, Nguyen R, et al. Cytopathologic identification of circulating tumor cells (CTCs) in breast cancer: Application of size-based enrichment. Clin Diagnostic Pathol 2019; 3: 1–5. doi: 10.15761/ CDP.1000S1001
- Marrinucci D, Bethel K, Bruce RH, Curry DN, Hsieh B, Humphrey M, et al. Case study of the morphologic variation of circulating tumor cells. Hum Pathol 2007; 38: 514–9. doi: 10.1016/j.humpath.2006.08.027
- Hattori M, Nakanishi H, Yoshimura M, Iwase M, Yoshimura A, Adachi Y, et al. Circulating tumor cells detection in tumor draining vein of breast cancer patients. Sci Rep 2019; 9: 18195. doi: 10.1038/s41598-019-54839-y
- Tsutsuyama M, Nakanishi H, Yoshimura M, Oshiro T, Kinoshita T, Komori K, et al. Detection of circulating tumor cells in drainage venous blood from colorectal cancer patients using a new filtration and cytology-based automated platform. PLoS One 2019; 14: e0212221. doi: 10.1371/journal. pone.0212221
- Kuvendjiska J, Pitman MB, Martini V, Braun C, Grebe K, Timme S, et al. Cytopathological heterogeneity of circulating tumor cells in non-metastatic esophageal adenocarcinoma. Anticancer Res 2020; 40: 5679–85. doi: 10.21873/anticanres.14582
- Lee AV, Oesterreich S, Davidson NE. MCF-7 cells - changing the course of breast cancer research and care for 45 years. J Natl Cancer Inst 2015; 107: djv073. doi: 10.1093/jnci/djv073
- Koch C, Joosse SA, Schneegans S, Wilken OJW, Janning M, Loreth D, et al. Pre-analytical and analytical variables of label-independent enrichment and automated detection of circulating tumor cells in cancer patients. Cancers 2020; 12: 442. doi: 10.3390/cancers12020442
- Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nature Methods 2012; 9: 671–5. doi: 10.1038/nmeth.2089
- Xu L, Mao X, Imrali A, Syed F, Mutsvangwa K, Berney D, et al. Optimization and evaluation of a novel size based circulating tumor cell isolation system. PLoS One 2015; 10: e0138032. doi: 10.1371/journal.pone.0138032
- Maertens Y, Humberg V, Erlmeier F, Steffens S, Steinestel J, Bögemann M, et al. Comparison of isolation platforms for detection of circulating renal cell carcinoma cells. Oncotarget, 2017; 8: 87710–7. doi: 10.18632/oncotarget.21197
- Kitz J, Goodale D, Postenka C, Lowes LE, Allan AL. EMT-independent detection of circulating tumor cells in human blood samples and preclinical mouse models of metastasis. Clin Exp Metastasis 2021; 38: 97-108. doi:10.1007/s10585-020-10070-y.
- Pan L, Yan G, Chen W, Sun L, Wang J, Yang J. Distribution of circulating tumor cell phenotype in early cervical cancer. Cancer Manag Res 2019; 11: 5531–5536. doi: 10.2147/CMAR.S19839.
- Zhang S, Wu T, Peng X, Liu J, Liu F, Wu S, et al. Mesenchymal phenotype of circulating tumor cells is associated with distant metastasis in breast cancer patients. Cancer Manag Res 2017; 9: 691–700. doi: 10.2147/CMAR. S149801
- Messaritakis I, Politaki E, Kotsakis A, Dermitzaki EK, Koinis F, Lagoudaki E, et al. Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer. PLoS One 2017; 12: e0181211. doi: 10.1371/journal.pone.0181211
- Dey P. Routine staining in cytology laboratory. In: Basic and advanced laboratory techniques in histopathology and cytology. Singapore: Springer; 2018. p. 133–8.